Main > NEUROLOGY. > Multiple Sclerosis > Treatment > TNF-Alpha Inhibitor > MAb Type TNF-Alpha Inhibitor > Patent > Claims > Claim 1: Multiple Sclerosis Treat.: > Adm. Monoclonal Anti-TNF Alpha > Antibody. Claim 3: Pharma Vehicle > Claim 4: Direct Adm. to CNS. Claim > 5: Adm. IntraThecally. Claim 6: > Antigen Binding Antibody Fragment. > Patent Assignee
Patent Assignee's products
UK. K